Nordian Capital Partners has sold IGS GeboJagema to Smile Invest and Rabo Corporate Investments

Smile Invest has become the majority shareholder of IGS alongside minority investor Rabo Corporate Investments and management.

IGS is a full-service partner for high-precision, high-volume injection molds to leading original equipment manufacturers (OEMs) and contract manufacturing organizations in the healthcare devices and ophthalmic end markets. The company’s unique value proposition combines Industry 4.0 manufacturing capabilities with an end-to-end service offering, spanning design, engineering, qualification and support services. Based in Eindhoven, the Netherlands, IGS employs approximately 120 full-time employees and realized double-digit annual revenue growth during the past decade.

With Smile Invest on board as a new owner, the company plans to accelerate its expansion into the United States, continue to broaden its presence in long-running medical device platforms and expand into other end markets such as medical packaging.

Sibert Meulenbelt, Managing Director at Lincoln, commented, “It has been a pleasure to work with Nordian and the management team of IGS. They have built a company that is recognized by the world’s leading OEMs to keep raising the bar in terms of quality, which the company emanated throughout the process as well.”

Lincoln acted as the exclusive investment banking advisor to IGS, working closely with its shareholders and the management team throughout the sale process.

Nordian IGS Smile 2021
  • 2021
    Close Year
  • Industrials
    Industry
  • Private Equity
    Client Type
  • Financial | Cross-border
    Transaction Type
  • Belgium | Netherlands
    Countries
Lincoln’s dedicated team, industry expertise and in-depth knowledge of IGS were instrumental in realizing a successful outcome of the process.
Perry Bos
Managing Partner at Nordian

Meet our Senior Team